These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22526297)

  • 1. Inhibition of soluble epoxide hydrolase limits niacin-induced vasodilation in mice.
    Inceoglu AB; Clifton HL; Yang J; Hegedus C; Hammock BD; Schaefer S
    J Cardiovasc Pharmacol; 2012 Jul; 60(1):70-5. PubMed ID: 22526297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redox regulation of soluble epoxide hydrolase by 15-deoxy-delta-prostaglandin J2 controls coronary hypoxic vasodilation.
    Charles RL; Burgoyne JR; Mayr M; Weldon SM; Hubner N; Dong H; Morisseau C; Hammock BD; Landar A; Eaton P
    Circ Res; 2011 Feb; 108(3):324-34. PubMed ID: 21164107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonism of the prostaglandin D2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans.
    Cheng K; Wu TJ; Wu KK; Sturino C; Metters K; Gottesdiener K; Wright SD; Wang Z; O'Neill G; Lai E; Waters MG
    Proc Natl Acad Sci U S A; 2006 Apr; 103(17):6682-7. PubMed ID: 16617107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release of markedly increased quantities of prostaglandin D2 in vivo in humans following the administration of nicotinic acid.
    Morrow JD; Parsons WG; Roberts LJ
    Prostaglandins; 1989 Aug; 38(2):263-74. PubMed ID: 2475889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRPV1 channels are involved in niacin-induced cutaneous vasodilation in mice.
    Clifton HL; Inceoglu B; Ma L; Zheng J; Schaefer S
    J Cardiovasc Pharmacol; 2015 Feb; 65(2):184-91. PubMed ID: 25387247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of niacin-induced vasodilation with an antagonist to prostaglandin D2 receptor subtype 1.
    Lai E; De Lepeleire I; Crumley TM; Liu F; Wenning LA; Michiels N; Vets E; O'Neill G; Wagner JA; Gottesdiener K
    Clin Pharmacol Ther; 2007 Jun; 81(6):849-57. PubMed ID: 17392721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanism and mitigation of niacin-induced flushing.
    Kamanna VS; Ganji SH; Kashyap ML
    Int J Clin Pract; 2009 Sep; 63(9):1369-77. PubMed ID: 19691622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of soluble epoxide hydrolase minimize ischemia-reperfusion-induced cardiac damage in normal, hypertensive, and diabetic rats.
    Islam O; Patil P; Goswami SK; Razdan R; Inamdar MN; Rizwan M; Mathew J; Inceoglu B; Stephen Lee KS; Hwang SH; Hammock BD
    Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28296232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble Epoxide Hydrolase Pharmacological Inhibition Decreases Alveolar Bone Loss by Modulating Host Inflammatory Response, RANK-Related Signaling, Endoplasmic Reticulum Stress, and Apoptosis.
    Trindade-da-Silva CA; Bettaieb A; Napimoga MH; Lee KSS; Inceoglu B; Ueira-Vieira C; Bruun D; Goswami SK; Haj FG; Hammock BD
    J Pharmacol Exp Ther; 2017 Jun; 361(3):408-416. PubMed ID: 28356494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble Epoxide Hydrolase Inhibition Attenuates MPTP-Induced Neurotoxicity in the Nigrostriatal Dopaminergic System: Involvement of α-Synuclein Aggregation and ER Stress.
    Huang HJ; Wang YT; Lin HC; Lee YH; Lin AM
    Mol Neurobiol; 2018 Jan; 55(1):138-144. PubMed ID: 28822080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble Epoxide Hydrolase Hepatic Deficiency Ameliorates Alcohol-Associated Liver Disease.
    Mello A; Hsu MF; Koike S; Chu B; Cheng J; Yang J; Morisseau C; Torok NJ; Hammock BD; Haj FG
    Cell Mol Gastroenterol Hepatol; 2021; 11(3):815-830. PubMed ID: 33068774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene deficiency and pharmacological inhibition of soluble epoxide hydrolase confers resilience to repeated social defeat stress.
    Ren Q; Ma M; Ishima T; Morisseau C; Yang J; Wagner KM; Zhang JC; Yang C; Yao W; Dong C; Han M; Hammock BD; Hashimoto K
    Proc Natl Acad Sci U S A; 2016 Mar; 113(13):E1944-52. PubMed ID: 26976569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omeprazole increases the efficacy of a soluble epoxide hydrolase inhibitor in a PGE₂ induced pain model.
    Goswami SK; Inceoglu B; Yang J; Wan D; Kodani SD; da Silva CA; Morisseau C; Hammock BD
    Toxicol Appl Pharmacol; 2015 Dec; 289(3):419-27. PubMed ID: 26522832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble epoxide hydrolase inhibition is antinociceptive in a mouse model of diabetic neuropathy.
    Wagner K; Yang J; Inceoglu B; Hammock BD
    J Pain; 2014 Sep; 15(9):907-14. PubMed ID: 24924124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine A2A receptor modulates vascular response in soluble epoxide hydrolase-null mice through CYP-epoxygenases and PPARγ.
    Nayeem MA; Pradhan I; Mustafa SJ; Morisseau C; Falck JR; Zeldin DC
    Am J Physiol Regul Integr Comp Physiol; 2013 Jan; 304(1):R23-32. PubMed ID: 23152114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of soluble epoxide hydrolase confers cardioprotection and prevents cardiac cytochrome P450 induction by benzo(a)pyrene.
    Aboutabl ME; Zordoky BN; Hammock BD; El-Kadi AO
    J Cardiovasc Pharmacol; 2011 Mar; 57(3):273-81. PubMed ID: 21383588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of aspirin when added to the prostaglandin D2 receptor antagonist laropiprant on niacin-induced flushing symptoms.
    Dishy V; Liu F; Ebel DL; Atiee GJ; Royalty J; Reilley S; Paolini JF; Wagner JA; Lai E
    J Clin Pharmacol; 2009 Apr; 49(4):416-22. PubMed ID: 19246721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological inhibition of soluble epoxide hydrolase or genetic deletion reduces diclofenac-induced gastric ulcers.
    Goswami SK; Rand AA; Wan D; Yang J; Inceoglu B; Thomas M; Morisseau C; Yang GY; Hammock BD
    Life Sci; 2017 Jul; 180():114-122. PubMed ID: 28522175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Soluble Epoxide Hydrolase Inhibitor, 1-TrifluoromethoxyPhenyl-3-(1-Propionylpiperidin-4-yl) Urea, Ameliorates Experimental Autoimmune Encephalomyelitis.
    Jonnalagadda D; Wan D; Chun J; Hammock BD; Kihara Y
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of skin as a major site of prostaglandin D2 release following oral administration of niacin in humans.
    Morrow JD; Awad JA; Oates JA; Roberts LJ
    J Invest Dermatol; 1992 May; 98(5):812-5. PubMed ID: 1373750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.